Phytochemical based nanomedicines against cancer: current status and future prospects

References

• American Cancer Society. Cancer facts & figures 2015. Atlanta (GA): American Cancer Society; 2015.
   Google Scholar
• Li B, Gao MH, Chu XM, et al. The synergistic antitumor effects of all-trans retinoic acid and C-phycocyanin on the lung cancer A549 cells in vitro and in vivo. Eur J Pharmacol. 2015;749:107–114.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2015;65:5–29.
   PubMed Web of Science ®Google Scholar
• Liang XJ, Chen C, Zhao Y, et al. Circumventing tumor resistance to chemotherapy by nanotechnology. Methods Mol Biol. 2010;596:467–488.
   PubMedGoogle Scholar
• Liu RH. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr. 2003;78:517S–520S.
   PubMed Web of Science ®Google Scholar
• Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 2003;3:768–780.
   PubMed Web of Science ®Google Scholar
• Basnet P, Skalko-Basnet N. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules. 2011;16:4567–4598.
   PubMed Web of Science ®Google Scholar
• Xie J, Yang Z, Zhou C, et al. Nanotechnology for the delivery of phytochemicals in cancer therapy. Biotechnol Adv. 2016;34:343–353.
   PubMed Web of Science ®Google Scholar
• Ahmad J, Akhter S, Rizwanullah M, et al. Nanotechnology-based inhalation treatments for lung cancer: state of the art. Nanotechnol Sci Appl. 2015;8:55–66.
   PubMed Web of Science ®Google Scholar
• Bhadoriya SS, Mangal A, Madoriya N, et al. Bioavailability and bioactivity enhancement of herbal drugs by nanotechnology: a review. J Curr Pharm Res. 2011;8:1–7.
   Google Scholar
• Maeda H, Nakamura H, Fang J. The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv Drug Deliv Rev. 2013;65:71–79.
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011;63:136–151.
   PubMed Web of Science ®Google Scholar
• Bertrand N, Wu J, Xu X, et al. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 2014;66:2–25.
   PubMed Web of Science ®Google Scholar
• Biswas S, Torchilin VP. Nanopreparations for organelle-specific delivery in cancer. Adv Drug Deliv Rev. 2014;66:26–41.
   PubMed Web of Science ®Google Scholar
• Patel NR, Pattni BS, Abouzeid AH, et al. Nanopreparations to overcome multidrug resistance in cancer. Adv Drug Deliv Rev. 2013;65:1748–1762.
   PubMed Web of Science ®Google Scholar
• Peetla C, Vijayaraghavalu S, Labhasetwar V. Biophysics of cell membrane lipids in cancer drug resistance: implications for drug transport and drug delivery with nanoparticles. Adv Drug Deliv Rev. 2013;65:1686–1698.
   PubMed Web of Science ®Google Scholar
• Jain V, Jain S, Mahajan SC. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment. Curr Drug Deliv. 2015;12:177–191.
   PubMed Web of Science ®Google Scholar
• Singh R, Tiwari S, Tawaniya J. Review on nanotechnology with several aspects. Int J Res Comput Eng Electron. 2013;2:1–8.
   Google Scholar
• Holst B, Williamson G. Nutrients and phytochemicals: from bioavailability to bioefficacy beyond antioxidants. Curr Opin Biotechnol. 2008;19:73–82.
   PubMed Web of Science ®Google Scholar
• Jeetah R, Bhaw-Luximon A, Jhurry D. Nanopharmaceutics: phytochemical-based controlled or sustained drug-delivery systems for cancer treatment. J Biomed Nanotechnol. 2014;10:1810–1840.
   PubMed Web of Science ®Google Scholar
• Tan W, Li Y, Chen M, et al. Berberine hydrochloride: anticancer activity and nanoparticulate delivery system. Int J Nanomedicine. 2011;6:1773–1777.
   PubMedGoogle Scholar
• Mahmoudian M, Rahimi-Moghaddam P. The anti-cancer activity of noscapine: a review. Recent Pat Anticancer Drug Discov. 2009;4:92–97.
   PubMed Web of Science ®Google Scholar
• Sriram D, Yogeeswari P, Thirumurugan R, et al. Camptothecin and its analogues: a review on their chemotherapeutic potential. Nat Prod Res. 2005;19:393–412.
   PubMed Web of Science ®Google Scholar
• Butt MS, Naz A, Sultan MT, et al. Anti-oncogenic perspectives of spices/herbs: a comprehensive review. EXCLI J. 2013;12:1043–1065.
   PubMed Web of Science ®Google Scholar
• Chen YJ. Potential role of tetrandrine in cancer therapy. Acta Pharmacol Sin. 2002;23:1102–1106.
   PubMed Web of Science ®Google Scholar
• Moudi M, Go R, Yien CYS, et al. Vinca alkaloids. Int J Prev Med. 2013;4:1231–1235.
   PubMedGoogle Scholar
• Yin PH, Liu X, Qiu YY, et al. Anti-tumor activity and apoptosis-regulation mechanisms of bufalin in various cancers: new hope for cancer patients. Asian Pac J Cancer Prev. 2012;13:5339–5343.
   PubMedGoogle Scholar
• Kashyap D, Mondal R, Tuli HS, et al. Molecular targets of gambogic acid in cancer: recent trends and advancements. Tumour Biol. 2016;37:12915–12925.
   PubMedGoogle Scholar
• Wei WT, Lin SZ, Liu DL, et al. The distinct mechanisms of the antitumor activity of emodin in different types of cancer (review). Oncol Rep. 2013;30:2555–2562.
   PubMed Web of Science ®Google Scholar
• Kung HN, Lu KS, Chau YP. The chemotherapeutic effects of lapacho tree extract: β-lapachone. Chemotherapy. 2014;3:1–5.
   Google Scholar
• Woo CC, Kumar AP, Sethi G, et al. Thymoquinone: potential cure for inflammatory disorders and cancer. Biochem Pharmacol. 2012;83:443–451.
   PubMed Web of Science ®Google Scholar
• Ahmad MZ, Alkahtani SA, Akhter S, et al. Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art. J Drug Target. 2016;24:273–293.
   PubMed Web of Science ®Google Scholar
• You Y. Podophyllotoxin derivatives: current synthetic approaches for new anticancer agents. Curr Pharm Des. 2005;11:1695–1717.
   PubMed Web of Science ®Google Scholar
• Fried LE, Arbiser JL. Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxid Redox Signal. 2009;11:1139–1148.
   PubMed Web of Science ®Google Scholar
• Das AK. Anticancer effect of AntiMalarial Artemisinin compounds. Ann Med Health Sci Res. 2015;5:93–102.
   PubMed Web of Science ®Google Scholar
• Rahman HS, Rasedee A, Yeap SK, et al. Biomedical properties of a natural dietary plant metabolite, zerumbone, in cancer therapy and chemoprevention trials. Biomed Res Int. 2014;2014:920742.
   PubMed Web of Science ®Google Scholar
• Sangwan V, Saluja AK. Mechanism of action of the anti-cancer agent, triptolide. In: Sarkar FH, editor. Nutraceuticals and cancer. The Netherlands: Springer; 2015. p. 135150.
   Google Scholar
• Orlikova B, Tasdemir D, Golais F, et al. Dietary chalcones with chemopreventive and chemotherapeutic potential. Genes Nutr. 2011;6:125–147.
   PubMed Web of Science ®Google Scholar
• Kaushik U, Aeri V, Mir SR. Cucurbitacins - An insight into medicinal leads from nature. Pharmacogn Rev. 2015;9:12–18.
   PubMedGoogle Scholar
• Fulda S. Betulinic acid for cancer treatment and prevention. Int J Mol Sci. 2008;9:1096–1107.
   PubMed Web of Science ®Google Scholar
• Shanmugam MK, Dai X, Kumar AP, et al. Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: preclinical and clinical evidence. Cancer Lett. 2014;346:206–216.
   PubMed Web of Science ®Google Scholar
• Shanmugam MK, Dai X, Kumar AP, et al. Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies. Biochem Pharmacol. 2013;85:1579–1587.
   PubMed Web of Science ®Google Scholar
• Varoni EM, Faro AFL, Sharifi-Rad J, et al. Anticancer molecular mechanisms of resveratrol. Front Nutr. 2016;3:1–15.
   PubMed Web of Science ®Google Scholar
• Tozer GM, Kanthou C, Parkins CS, et al. The biology of the combretastatins as tumour vascular targeting agents. Int J Exp Pathol. 2002;83:21–38.
   PubMed Web of Science ®Google Scholar
• Zhang HM, Zhao L, Li H, et al. Research progress on the anticarcinogenic actions and mechanisms of ellagic acid. Cancer Biol Med. 2014;11:92–100.
   PubMedGoogle Scholar
• Srinivasan M, Sudheer AR, Menon VP. Ferulic acid: therapeutic potential through its antioxidant property. J Clin Biochem Nutr. 2007;40:92–100.
   PubMed Web of Science ®Google Scholar
• Kim SH, Choi KC. Anti-cancer effect and underlying mechanism(s) of kaempferol, a phytoestrogen, on the regulation of apoptosis in diverse cancer cell models. Toxicol Res. 2013;29:229–234.
   PubMedGoogle Scholar
• Park C, Lee WS, Go SI, et al. Morin, a flavonoid from moraceae, induces apoptosis by induction of BAD protein in human leukemic cells. Int J Mol Sci. 2014;16:645–659.
   PubMed Web of Science ®Google Scholar
• Khan F, Niaz K, Maqbool F, et al. Molecular targets underlying the anticancer effects of quercetin: an update. Nutrients. 2016;8:529–E529.
   PubMed Web of Science ®Google Scholar
• Shukla S, Gupta S. Apigenin: a promising molecule for cancer prevention. Pharm Res. 2010;27:962–978.
   PubMed Web of Science ®Google Scholar
• Lin Y, Shi R, Wang X, et al. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets. 2008;8:634–646.
   PubMed Web of Science ®Google Scholar
• Rawson NE, Ho CT, Li S. Efficacious anti-cancer property of flavonoids from citrus peels. Food Sci Human Wellness. 2014;3:104–109.
   Google Scholar
• Singh BN, Shankar S, Srivastava RK. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol. 2011;82:1807–1821.
   PubMed Web of Science ®Google Scholar
• Roohbakhsh A, Parhiz H, Soltani F, et al. Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases. Life Sci. 2015;124:64–74.
   PubMed Web of Science ®Google Scholar
• Mir IA, Tiku AB. Chemopreventive and therapeutic potential of “naringenin,” a flavanone present in citrus fruits. Nutr Cancer. 2015;67:27–42.
   PubMed Web of Science ®Google Scholar
• Li QS, Li CY, Li ZL, et al. Genistein and its synthetic analogs as anticancer agents. Anticancer Agents Med Chem. 2012;12:271–281.
   PubMed Web of Science ®Google Scholar
• Ting H, Deep G, Agarwal R. Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer. AAPS J. 2013;15:707–716.
   PubMed Web of Science ®Google Scholar
• Aqil F, Munagala R, Jeyabalan J, et al. Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Lett. 2013;334:133–141.
   PubMed Web of Science ®Google Scholar
• Ahmad J, Akhter S, Greig NH, et al. Engineered nanoparticles against MDR in cancer: the state of the art and its prospective. Curr Pharm Des. 2016;22:4360–4373.
   PubMed Web of Science ®Google Scholar
• Ahmad J, Amin S, Rahman M, et al. Solid matrix based lipidic nanoparticles in oral cancer chemotherapy: applications and pharmacokinetics. Curr Drug Metab. 2015;16:633–644.
   PubMed Web of Science ®Google Scholar
• Li C, Zhang J, Zu YJ, et al. Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals. Chin J Nat Med. 2015;13:641–652.
   PubMed Web of Science ®Google Scholar
• Gao Y, Xie J, Chen H, et al. Nanotechnology-based intelligent drug design for cancer metastasis treatment. Biotechnol Adv. 2014;32:761–777.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev. 2006;58:1532–1555.
   PubMed Web of Science ®Google Scholar
• Jia F, Liu X, Li L, et al. Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents. J Control Release. 2013;172:1020–1034.
   PubMed Web of Science ®Google Scholar
• Bronich T. Multifunctional polymeric carriers for gene and drug delivery. Pharm Res. 2010;27:2257–2259.
   PubMed Web of Science ®Google Scholar
• Cao Y, Wang B, Lou D, et al. Nanoscale delivery systems for multiple drug combinations in cancer. Future Oncol. 2011;7:1347–1357.
   PubMed Web of Science ®Google Scholar
• Maeda H, Bharate GY, Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm. 2009;71:409–419.
   PubMed Web of Science ®Google Scholar
• Ali Z, Abbasi AZ, Zhang F, et al. Multifunctional nanoparticles for dual imaging. Anal Chem. 2011;83:2877–2882.
   PubMed Web of Science ®Google Scholar
• Rahman M, Ahmad MZ, Kazmi I, et al. Advancement in multifunctional nanoparticles for the effective treatment of cancer. Expert Opin Drug Deliv. 2012;9:367–381.
   PubMed Web of Science ®Google Scholar
• Glasgow MD, Chougule MB. Recent developments in active tumor targeted multifunctional nanoparticles for combination chemotherapy in cancer treatment and imaging. J Biomed Nanotechnol. 2015;11:1859–1898.
   Google Scholar
• Cheng Y, Morshed R, Auffinger B, et al. Multifunctional nanoparticles for brain tumor imaging and therapy. Adv Drug Deliv Rev. 2014;66:42–57.
   PubMed Web of Science ®Google Scholar
• Jain RK. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J Control Release. 2001;74:7–25.
   PubMed Web of Science ®Google Scholar
• Gao Z, Zhang L, Sun Y. Nanotechnology applied to overcome tumor drug resistance. J Control Release. 2012;162:45–55.
   PubMed Web of Science ®Google Scholar
• Liu Y, Lu W. Recent advances in brain tumor-targeted nano-drug delivery systems. Expert Opin Drug Deliv. 2012;9:671–686.
   PubMed Web of Science ®Google Scholar
• Dhanasekaran SM, Barrette TR, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature. 2001;412:822–826.
   PubMed Web of Science ®Google Scholar
• Goel S, Duda DG, Xu L, et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev. 2011;91:1071–1021.
   PubMed Web of Science ®Google Scholar
• Rizwanullah M, Ahmad J, Amin S. Nanostructured lipid carriers: a novel platform for chemotherapeutics. Curr Drug Deliv. 2016;13:4–26.
   PubMed Web of Science ®Google Scholar
• Akhter MH, Rizwanullah M, Ahmad J, et al. Nanocarriers in advanced drug targeting: setting novel paradigm in cancer therapeutics. Artif Cells Nanomed Biotechnol. 2017;22:1–12.
   PubMed Web of Science ®Google Scholar
• Akhter S, Amin S, Ahmad J, et al. Nanotechnology to combat multidrug resistance in cancer. In: Efferth T, editor. Resistance to targeted anti-cancer therapeutics. Switzerland: Springer International Publishing group; 2015. p. 245272.
   Google Scholar
• Mehra NK, Mishra V, Jain NK. Receptor-based targeting of therapeutics. Ther Deliv. 2013;4:369–394.
   PubMedGoogle Scholar
• Ahmad J, Kohli K, Mir SR, et al. Lipid based nanocarriers for oral delivery of cancer chemotherapeutics: an insight in the intestinal lymphatic transport. Drug Deliv lett. 2013;3:38–46.
   Google Scholar
• de Verdière AC, Dubernet C, Némati F, et al. Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. Br J Cancer. 1997;76:198–205.
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Targeting cancer cells by exploiting their resistance. Trends Mol Med. 2003;9:307–312.
   PubMed Web of Science ®Google Scholar
• Arias JL, Clares B, Morales ME, et al. Lipid-based drug delivery systems for cancer treatment. Curr Drug Targets. 2011;12:1151–1165.
   PubMed Web of Science ®Google Scholar
• Malam Y, Loizidou M, Seifalian AM. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci. 2009;30:592–599.
   PubMed Web of Science ®Google Scholar
• Mullauer FB, van Bloois L, Daalhuisen JB, et al. Betulinic acid delivered in liposomes reduces growth of human lung and colon cancers in mice without causing systemic toxicity. Anticancer Drugs. 2011;22:223–233.
   PubMed Web of Science ®Google Scholar
• de Pace RC, Liu X, Sun M, et al. Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells. J Liposome Res. 2013;23:187–196.
   PubMed Web of Science ®Google Scholar
• Li XT, He ML, Zhou ZY, et al. The antitumor activity of PNA modified vinblastine cationic liposomes on Lewis lung tumor cells: in vitro and in vivo evaluation. Int J Pharm. 2015;487:223–233.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhao H, Duan LR, et al. Preparation, characterization and evaluation of bufalin liposomes coated with citrus pectin. Colloids Surf A Physicochem Eng Asp.2014;444:54–62.
   Web of Science ®Google Scholar
• Dadgar N, Alavi SE, Esfahani MK, et al. Study of toxicity effect of pegylated nanoliposomal artemisinin on breast cancer cell line. Ind J Clin Biochem. 2013;28:410–412.
   PubMedGoogle Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47:165–196.
   PubMed Web of Science ®Google Scholar
• Martins S, Sarmento B, Ferreira DC, et al. Lipid-based colloidal carriers for peptide and protein delivery – liposomes versus lipid nanoparticles. Int J Nanomedicine. 2007;2:595–607.
   PubMed Web of Science ®Google Scholar
• Hu H, Liu D, Zhao X, et al. Preparation, characterization, cellular uptake and evaluation in vivo of solid lipid nanoparticles loaded with cucurbitacin B. Drug Dev Ind Pharm. 2013;39:770–779.
   PubMed Web of Science ®Google Scholar
• Zhu RR, Qin LL, Wang M, et al. Preparation, characterization, and anti-tumor property of podophyllotoxin-loaded solid lipid nanoparticles. Nanotechnology. 2009;20:055702.
   PubMed Web of Science ®Google Scholar
• Madan J, Pandey RS, Jain V, et al. Poly (ethylene)-glycol conjugated solid lipid nanoparticles of noscapine improve biological half-life, brain delivery and efficacy in glioblastoma cells. Nanomedicine. 2013;9:492–503.
   PubMed Web of Science ®Google Scholar
• Wang L, Li H, Wang S, et al. Enhancing the antitumor activity of berberine hydrochloride by solid lipid nanoparticle encapsulation. AAPS PharmSciTech. 2014;15:834–844.
   PubMed Web of Science ®Google Scholar
• Chen R, Wang S, Zhang J, et al. Aloe-emodin loaded solid lipid nanoparticles: formulation design and in vitro anti-cancer study. Drug Deliv. 2015;22:666–674.
   PubMed Web of Science ®Google Scholar
• Rizwanullah M, Amin S, Ahmad J. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers. J Drug Target. 2017;25:58–74.
   PubMed Web of Science ®Google Scholar
• Lin M, Teng L, Wang Y, et al. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy. Drug Deliv. 2016;23:1420–1425.
   PubMed Web of Science ®Google Scholar
• Jyoti K, Kaur K, Pandey RS, et al. Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies. J Colloid Interface Sci. 2015;445:219–230.
   PubMed Web of Science ®Google Scholar
• Ng WK, Saiful Yazan L, Yap LH, et al. Thymoquinone-loaded nanostructured lipid carrier exhibited cytotoxicity towards breast cancer cell lines (MDA-MB-231 and MCF-7) and cervical cancer cell lines (HeLa and SiHa). Biomed Res Int. 2015;2015:263131
   PubMed Web of Science ®Google Scholar
• Zhang XY, Qiao H, Ni JM, et al. Preparation of isoliquiritigenin-loaded nanostructured lipid carrier and the in vivo evaluation in tumor-bearing mice. Eur J Pharm Sci. 2013;49:411–422.
   PubMed Web of Science ®Google Scholar
• Carbone C, Campisi A, Musumeci T, et al. FA-loaded lipid drug delivery systems: preparation, characterization and biological studies. Eur J Pharm Sci. 2014;52:12–20.
   PubMed Web of Science ®Google Scholar
• Rahman HS, Rasedee A, How CW, et al. Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect. Int J Nanomedicine. 2013;8:2769–2781.
   PubMed Web of Science ®Google Scholar
• Lukyanov AN, Torchilin VP. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev. 2004;56:1273–1289.
   PubMed Web of Science ®Google Scholar
• Munyendo WL, Zhang Z, Abbad S, et al. Micelles of TPGS modified apigenin phospholipid complex for oral administration: preparation, in vitro and in vivo evaluation. J Biomed Nanotechnol. 2013;9:2034–2047.
   PubMed Web of Science ®Google Scholar
• Tan BJ, Liu Y, Chang KL, et al. Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer. Int J Nanomedicine. 2012;7:651–661.
   PubMed Web of Science ®Google Scholar
• Prabhu RH, Patravale VB, Joshi MD. Polymeric nanoparticles for targeted treatment in oncology: current insights. Int J Nanomedicine. 2015;10:1001–1018.
   PubMed Web of Science ®Google Scholar
• Chen J, Li S, Shen Q, et al. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer. Drug Dev Ind Pharm. 2011;37:1339–1346.
   PubMed Web of Science ®Google Scholar
• Yang A, Liu Z, Yan B, et al. Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22. Drug Deliv. 2016;23:1699–1706.
   PubMed Web of Science ®Google Scholar
• Zu Y, Meng L, Zhao X, et al. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery. Int J Nanomedicine. 2013;8:1207–1222.
   PubMed Web of Science ®Google Scholar
• Wu B, Liang Y, Tan Y, et al. Genistein-loaded nanoparticles of star-shaped diblock copolymer mannitol-core PLGA-TPGS for the treatment of liver cancer. Mater Sci Eng C Mater Biol Appl. 2016;59:792–800.
   PubMed Web of Science ®Google Scholar
• Gurushankar K, Gohulkumar M, Prasad NR, et al. Synthesis, characterization and in vitro anti-cancer evaluation of hesperetin-loaded nanoparticles in human oral carcinoma (KB) cells. Adv Nat Sci Nanosci Nanotechnol. 2013;5:015006.
   Web of Science ®Google Scholar
• Zhang Y, Chen T, Yuan P, et al. Encapsulation of honokiol into self-assembled pectin nanoparticles for drug delivery to HepG2 cells. Carbohydr Polym. 2015;133:31–38.
   PubMed Web of Science ®Google Scholar
• Arulmozhi V, Pandian K, Mirunalini S. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB). Colloids Surf B Biointerfaces. 2013;110:313–320.
   PubMed Web of Science ®Google Scholar
• Kumar SP, Birundha K, Kaveri K, et al. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells. Int J Biol Macromol. 2015;78:87–95.
   PubMed Web of Science ®Google Scholar
• Luque-Alcaraz AG, Lizardi J, Goycoolea FM, et al. Characterization and antiproliferative activity of nobiletin-loaded chitosan nanoparticles. J Nanomater. 2012;2012:265161.
   Web of Science ®Google Scholar
• Xu H, Hou Z, Zhang H, et al. An efficient Trojan delivery of tetrandrine by poly(N-vinylpyrrolidone)-block-poly(ε-caprolactone) (PVP-b-PCL) nanoparticles shows enhanced apoptotic induction of lung cancer cells and inhibition of its migration and invasion. Int J Nanomedicine. 2014;9:231–242.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang Z, Tan X, et al. Development of a more efficient albumin-based delivery system for gambogic acid with Low toxicity for lung cancer therapy. AAPS PharmSciTech. 2017;18:1987–1997.
   Web of Science ®Google Scholar
• Majumdar D, Jung KH, Zhang H, et al. Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity. Cancer Prev Res (Phila). 2014;7:65–73.
   PubMed Web of Science ®Google Scholar
• Bao X, Gao M, Xu H, et al. A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment. Drug Dev Ind Pharm. 2015;41:1193–1203.
   PubMed Web of Science ®Google Scholar
• Pachauri M, Gupta ED, Ghosh PC. Piperine loaded PEG-PLGA nanoparticles: preparation, characterization and targeted delivery for adjuvant breast cancer chemotherapy. J Drug Deliv Sci Technol. 2015;29:269–282.
   Web of Science ®Google Scholar
• Movassaghian S, Merkel OM, Torchilin VP. Applications of polymer micelles for imaging and drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015;7:691–707.
   PubMed Web of Science ®Google Scholar
• Saxena V, Hussain MD. Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer. J Biomed Nanotechnol. 2013;9:1146–1154.
   PubMed Web of Science ®Google Scholar
• Zheng S, Löw K, Wagner S, et al. Cytotoxicity of triptolide and triptolide loaded polymeric micelles in vitro. Toxicol In Vitro. 2011;25:1557–1567.
   PubMed Web of Science ®Google Scholar
• Blanco E, Bey EA, Dong Y, et al. β-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells. J Control Release. 2007;122:365–374.
   PubMed Web of Science ®Google Scholar
• Zhai Y, Guo S, Liu C, et al. Preparation and in vitro evaluation of apigenin-loaded polymeric micelles. Colloids Surf A Physicochem Eng Asp.2013;429:24–30.
   Web of Science ®Google Scholar
• Wadhwa S, Mumper RJ. Polymer-drug conjugates for anticancer drug delivery. Crit Rev Ther Drug Carrier Syst. 2015;32:215–245.
   PubMed Web of Science ®Google Scholar
• Tang H, Murphy CJ, Zhang B, et al. Curcumin polymers as anticancer conjugates. Biomaterials. 2010;31:7139–7149.
   PubMed Web of Science ®Google Scholar
• Guo W, Li A, Jia Z, et al. Transferrin modified PEG-PLA-resveratrol conjugates: in vitro and in vivo studies for glioma. Eur J Pharmacol. 2013;718:41–47.
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Jain K, Jain NK. Dendrimer as nanocarrier for drug delivery. Prog Polym Sci. 2014;39:268–307.
   Web of Science ®Google Scholar
• Gao Y, Li Z, Xie X, et al. Dendrimeric anticancer prodrugs for targeted delivery of ursolic acid to folate receptor-expressing cancer cells: synthesis and biological evaluation. Eur J Pharm Sci. 2015;70:55–63.
   PubMed Web of Science ®Google Scholar
• Zhang M, Guo R, Wang Y, et al. Multifunctional dendrimer/combretastatin A4 inclusion complexes enable in vitro targeted cancer therapy. Int J Nanomedicine. 2011;6:2337–2349.
   PubMed Web of Science ®Google Scholar
• Wang F, Li C, Cheng J, et al. Recent advances on inorganic nanoparticle based cancer therapeutic agents. Int J Environ Res Public Health. 2016;13:1182–E1182.
   PubMed Web of Science ®Google Scholar
• Khiabani SS, Farshbaf M, Akbarzadeh A, et al. Magnetic nanoparticles: preparation methods, applications in cancer diagnosis and cancer therapy. Artif Cells Nanomed Biotechnol. 2017;45:6–17.
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Ebeling MC, Khan S, et al. Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment. Mol Cancer Ther. 2013;12:1471–1480.
   PubMed Web of Science ®Google Scholar
• Chen J, Guo Z, Wang HB, et al. Multifunctional mesoporous nanoparticles as pH-responsive Fe2+ reservoirs and artemisinin vehicles for synergistic inhibition of tumor growth. Biomaterials. 2014;35:6498–6507.
   PubMed Web of Science ®Google Scholar
• Cai W, Gao T, Hong H, et al. Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol Sci Appl. 2008;1:17–32.
   PubMedGoogle Scholar
• Chen CC, Hsieh DS, Huang KJ, et al. Improving anticancer efficacy of (-)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells. Drug Des Devel Ther. 2014;8:459–474.
   PubMed Web of Science ®Google Scholar
• Raghavan BS, Kondath S, Anantanarayanan R, et al. Kaempferol mediated synthesis of gold nanoparticles and their cytotoxic effects on MCF-7 cancer cell line. Process Biochem. 2015;50:1966–1976.
   Web of Science ®Google Scholar
• Kondath S, Raghavan BS, Anantanarayanan R, et al. Synthesis and characterisation of morin reduced gold nanoparticles and its cytotoxicity in MCF-7 cells. Chem Biol Interact. 2014;224:78–88.
   PubMed Web of Science ®Google Scholar
• Son KH, Hong JH, Lee JW. Carbon nanotubes as cancer therapeutic carriers and mediators. Int J Nanomedicine. 2016;11:5163–5185.
   PubMed Web of Science ®Google Scholar
• Tan JM, Karthivashan G, Arulselvan P, et al. Characterization and in vitro studies of the anticancer effect of oxidized carbon nanotubes functionalized with betulinic acid. Drug Des Devel Ther. 2014;8:2333–2343.
   PubMed Web of Science ®Google Scholar
• Tan JM, Karthivashan G, Arulselvan P, et al. Characterization and in vitro sustained release of silibinin from pH responsive carbon nanotube-based drug delivery system. J Nanomater. 2014;2014:439873.
   Web of Science ®Google Scholar
• Lin YC, Kuo JY, Hsu CC, et al. Optimizing manufacture of liposomal berberine with evaluation of its antihepatoma effects in a murine xenograft model. Int J Pharm. 2013;441:381–388.
   PubMed Web of Science ®Google Scholar
• Tang S, Gao D, Zhao T, et al. An evaluation of the anti-tumor efficacy of oleanolic acid-loaded PEGylated liposomes. Nanotechnology. 2013;24:235102.
   PubMed Web of Science ®Google Scholar
• Odeh F, Ismail SI, Abu-Dahab R, et al. Thymoquinone in liposomes: a study of loading efficiency and biological activity towards breast cancer. Drug Deliv. 2012;19:371–377.
   PubMed Web of Science ®Google Scholar
• Caldeira de Araújo Lopes S, Vinícius Melo Novais M, Salviano Teixeira C, et al. Preparation, physicochemical characterization, and cell viability evaluation of long-circulating and pH-sensitive liposomes containing ursolic acid. Biomed Res Int. 2013;2013:467147.
   PubMed Web of Science ®Google Scholar
• Martins SM, Sarmento B, Nunes C, et al. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration. Eur J Pharm Biopharm. 2013;85:488–502.
   PubMed Web of Science ®Google Scholar
• Wang W, Zhao X, Hu H, et al. Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability. Drug Deliv. 2010;17:114–122.
   PubMed Web of Science ®Google Scholar
• Chen Y, Pan L, Jiang M, et al. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo. Drug Deliv. 2016;23:1383–1392.
   PubMed Web of Science ®Google Scholar
• Sun M, Nie S, Pan X, et al. Quercetin-nanostructured lipid carriers: characteristics and anti-breast cancer activities in vitro. Colloids Surf B Biointerfaces.2014;113:15–24.
   PubMed Web of Science ®Google Scholar
• Gao X, Zhang J, Xu Q, et al. Hyaluronic acid-coated cationic nanostructured lipid carriers for oral vincristine sulfate delivery. Drug Dev Ind Pharm. 2017;43:661–667.
   PubMed Web of Science ®Google Scholar
• Cai L, Qiu N, Xiang M, et al. Improving aqueous solubility and antitumor effects by nanosized gambogic acid-mPEG2000 micelles. Int J Nanomedicine. 2014;9:243–255.
   PubMed Web of Science ®Google Scholar
• Tian X, Yin H, Zhang S, et al. Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma. Eur J Pharm Biopharm. 2014;87:445–453.
   PubMed Web of Science ®Google Scholar
• Siddiqui IA, Bharali DJ, Nihal M, et al. Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo. Nanomedicine. 2014;10:1619–1626.
   PubMed Web of Science ®Google Scholar
• Shirode AB, Bharali DJ, Nallanthighal S, et al. Nanoencapsulation of pomegranate bioactive compounds for breast cancer chemoprevention. Int J Nanomedicine. 2015;10:475–484.
   PubMed Web of Science ®Google Scholar
• Liu H, Gao M, Xu H, et al. A promising emodin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy. Pharm Res. 2016;33:217–236.
   PubMed Web of Science ®Google Scholar
• Merlin JPJ, Rajendra Prasad N, Shibli SMA, et al. Ferulic acid loaded Poly-D,L-lactide-co-glycolide nanoparticles: systematic study of particle size, drug encapsulation efficiency and anticancer effect in non-small cell lung carcinoma cell line in vitro. Biomed Prev Nutr. 2012;2:69–76.
   Google Scholar
• Zhang H, Liu G, Zeng X, et al. Fabrication of genistein-loaded biodegradable TPGS-b-PCL nanoparticles for improved therapeutic effects in cervical cancer cells. Int J Nanomedicine. 2015;10:2461–2473.
   PubMed Web of Science ®Google Scholar
• Abbad S, Wang C, Waddad AY, et al. Preparation, in vitro and in vivo evaluation of polymeric nanoparticles based on hyaluronic acid-poly(butyl cyanoacrylate) and D-alpha-tocopheryl polyethylene glycol 1000 succinate for tumor-targeted delivery of morin hydrate. Int J Nanomedicine. 2015;10:305–320.
   PubMed Web of Science ®Google Scholar
• Karthikeyan S, Prasad NR, Ganamani A, et al. Anticancer activity of resveratrol-loaded gelatin nanoparticles on NCI-H460 non-small cell lung cancer cells. Biomed Prevent Nutr. 2013;3:64–73.
   Google Scholar
• Pooja D, Babu Bikkina DJ, Kulhari H, et al. Fabrication, characterization and bioevaluation of silibinin loaded chitosan nanoparticles. Int J Biol Macromol. 2014;69:267–273.
   PubMed Web of Science ®Google Scholar
• Krishnakumar N, Sulfikkarali N, Prasad NR, et al. Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (HeLa) cancer cells. Biomed Prev Nutr. 2011;1:223–231.
   Google Scholar
• Wang Y, Yang T, Wang X, et al. Targeted polymeric micelle system for delivery of combretastatin A4 to tumor vasculature in vitro. Pharm Res. 2010;27:1861–1868.
   PubMed Web of Science ®Google Scholar
• Gou M, Men K, Shi H, et al. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale. 2011;3:1558–1567.
   PubMed Web of Science ®Google Scholar
• Saxena V, Hussain MD. Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer. Int J Nanomedicine. 2012;7:713–721.
   PubMed Web of Science ®Google Scholar
• Qiu JF, Gao X, Wang BL, et al. Preparation and characterization of monomethoxy poly(ethylene glycol)-poly(ε-caprolactone) micelles for the solubilization and in vivo delivery of luteolin. Int J Nanomedicine. 2013;8:3061–3069.
   PubMed Web of Science ®Google Scholar
• Zhao L, Shi Y, Zou S, et al. Formulation and in vitro evaluation of quercetin loaded polymeric micelles composed of pluronic P123 and D-a-tocopheryl polyethylene glycol succinate. J Biomed Nanotechnol. 2011;7:358–365.
   PubMed Web of Science ®Google Scholar
• Fang XB, Zhang JM, Xie X, et al. pH-sensitive micelles based on acid-labile pluronic F68-curcumin conjugates for improved tumor intracellular drug delivery. Int J Pharm. 2016;502:28–37.
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Xie L, Banerjee S, et al. Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. Colloids Surf B Biointerfaces. 2015;136:413–423.
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Othman SF, Curtis ET, et al. Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications. Int J Nanomedicine. 2012;7:1761–1779.
   PubMed Web of Science ®Google Scholar
• Mancarella S, Greco V, Baldassarre F, et al. Polymer-coated magnetic nanoparticles for curcumin delivery to cancer cells. Macromol Biosci. 2015;15:1365–1374.
   PubMed Web of Science ®Google Scholar
• Rajendran I, Dhandapani H, Anantanarayanan R, et al. Apigenin mediated gold nanoparticle synthesis and their anti-cancer effect on human epidermoid carcinoma (A431) cells. RSC Adv. 2015;5:51055–51066.
   Web of Science ®Google Scholar
• Hsieh DS, Lu HC, Chen CC, et al. The preparation and characterization of gold-conjugated polyphenol nanoparticles as a novel delivery system. Int J Nanomedicine. 2012;7:1623–1633.
   PubMed Web of Science ®Google Scholar
• Tan JM, Karthivashan G, Arulselvan P, et al. Sustained release and cytotoxicity evaluation of carbon nanotube-mediated drug delivery system for betulinic acid. J Nanomater. 2014;2014:862148.
   Web of Science ®Google Scholar
• Li H, Zhang N, Hao Y, et al. Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro. Drug Deliv. 2014;21:379–387.
   PubMed Web of Science ®Google Scholar
• Parhi P, Mohanty C, Sahoo SK. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy. Drug Discov Today. 2012;17:1044–1052.
   PubMed Web of Science ®Google Scholar
• Narayanan S, Mony U, Vijaykumar DK, et al. Sequential release of epigallocatechin gallate and paclitaxel from PLGA-casein core/shell nanoparticles sensitizes drug-resistant breast cancer cells. Nanomedicine. 2015;11:1399–1406.
   PubMed Web of Science ®Google Scholar
• Soni P, Kaur J, Tikoo K. Dual drug-loaded paclitaxel–thymoquinone nanoparticles for effective breast cancer therapy. J Nanopart Res. 2015;17:1–12.
   Web of Science ®Google Scholar
• Wang L, Wang W, Rui Z, et al. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system. Drug Deliv.2016;23:3200–3208.
   PubMed Web of Science ®Google Scholar
• Xu P, Wang R, Li J, et al. PEG-PLGA-PLL nanoparticles in combination with gambogic acid for reversing multidrug resistance of K562/A02 cells to daunorubicin. RSC Adv. 2015;5:61051–61059.
   Web of Science ®Google Scholar
• Mohan A, Narayanan S, Balasubramanian G, et al. Dual drug loaded nanoliposomal chemotherapy: a promising strategy for treatment of head and neck squamous cell carcinoma. Eur J Pharm Biopharm. 2016;99:73–83.
   PubMed Web of Science ®Google Scholar